Literature DB >> 21034421

Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.

Oleh Taratula1, Olga Garbuzenko, Ronak Savla, Y Andrew Wang, Huixin He, Tamara Minko.   

Abstract

The ability of Superparamagnetic Iron Oxide (SPIO) nanoparticles and Poly(Propyleneimine) generation 5 dendrimers (PPI G5) to cooperatively provoke siRNA complexation was investigated in order to develop a targeted, multifunctional siRNA delivery system for cancer therapy. Poly(ethylene glycol) (PEG) coating and cancer specific targeting moiety (LHRH peptide) have been incorporated into SPIO-PPI G5-siRNA complexes to enhance serum stability and selective internalization by cancer cells. Such a modification of siRNA nanoparticles enhanced its internalization into cancer cells and increased the efficiency of targeted gene suppression in vitro. Moreover, the developed siRNA delivery system was capable of sufficiently enhancing in vivo antitumor activity of an anticancer drug (Cisplatin). The proposed approach demonstrates potential for the creation of targeted multifunctional nanomedicine platforms with the ability to deliver therapeutic siRNA specifically to cancer cells in order to prevent severe adverse side effects on healthy tissues and in situ monitoring of the therapeutic outcome using clinically relevant imaging techniques.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21034421     DOI: 10.2174/156720111793663642

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  40 in total

Review 1.  Magnetic nanoparticles for cancer diagnosis and therapy.

Authors:  Mehmet V Yigit; Anna Moore; Zdravka Medarova
Journal:  Pharm Res       Date:  2012-01-25       Impact factor: 4.200

2.  Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy.

Authors:  Sanjay Singh
Journal:  Bioimpacts       Date:  2013-01-14

Review 3.  Nanomedicine therapeutic approaches to overcome cancer drug resistance.

Authors:  Janet L Markman; Arthur Rekechenetskiy; Eggehard Holler; Julia Y Ljubimova
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 4.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

5.  N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery.

Authors:  Gang Liu; Jin Xie; Fan Zhang; Zhiyong Wang; Kui Luo; Lei Zhu; Qimeng Quan; Gang Niu; Seulki Lee; Hua Ai; Xiaoyuan Chen
Journal:  Small       Date:  2011-08-22       Impact factor: 13.281

6.  Formulation and Delivery Technologies for mRNA Vaccines.

Authors:  Chunxi Zeng; Chengxiang Zhang; Patrick G Walker; Yizhou Dong
Journal:  Curr Top Microbiol Immunol       Date:  2020-06-02       Impact factor: 4.291

7.  Polymer nanocarriers for MicroRNA delivery.

Authors:  Chintan H Kapadia; Benjamin Luo; Megan N Dang; N'Dea Irvin-Choy; Danielle M Valcourt; Emily S Day
Journal:  J Appl Polym Sci       Date:  2019-11-12       Impact factor: 3.125

Review 8.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

9.  Self-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer.

Authors:  Chunbai He; Demin Liu; Wenbin Lin
Journal:  Biomaterials       Date:  2014-10-12       Impact factor: 12.479

10.  Theranostic agents for intracellular gene delivery with spatiotemporal imaging.

Authors:  Jennifer M Knipe; Jonathan T Peters; Nicholas A Peppas
Journal:  Nano Today       Date:  2013-02-01       Impact factor: 20.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.